Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Rodriguez-Alvarez, M.; Sarmini, L.; Kim, D. et al.
Direct detection f mutatins arising at a damage sith in DNANAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 393. H. SUPPL 1. 2020 S. 4-4
Messerschmidt, Clemens; Obermayer, Benedikt; Klinghammer, Konrad et al.
Distinct immune evasion inAPOBEC-enriched,HPV-negativeHNSCCINTERNATIONAL JOURNAL OF CANCER. Bd. 147. H. 8. 2020 S. 2293-2302
Degenhardt, Tom; Harbeck, Nadia; Fasching, Pater A. et al.
Documentation patterns and impact on observed side effects of the CANKADO ehealth application: An exploratory analysis of the PreCycle trial.JOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 15. 2020
Weiland, Thomas; Eckert, Alexander; Tomazic, Peter Valentin et al.
DRH1 - a novel blood-based HPV tumour markerEBIOMEDICINE. Bd. 56. 2020
Viardot, Andreas; Hess, Georg; Bargou, Ralf C. et al.
Durability of complete response after blinatumomab therapy for relapsed/refractory diffuse large B-cell lymphomaLEUKEMIA & LYMPHOMA. 2020
Faehling, Martin; Schumann, Christian; Christopoulos, Petros et al.
Durvalumab after definitive chemoradiotherapy in locally advanced unresectable non-small cell lung cancer (NSCLC): Real-world data on survival and safety from the German expanded-access program (EAP)LUNG CANCER. Bd. 150. 2020 S. 114-122
Becker, Cornelia; Graf, Norbert; Grabow, Desiree et al.
Early deaths from childhood cancer in Germany 1980-2016CANCER EPIDEMIOLOGY. Bd. 65. 2020
Kadioglu, Onat; Saeed, Mohamed E. M.; Munder, Markus et al.
Effect of ABC transporter expression and mutational status on survival rates of cancer patientsBIOMEDICINE & PHARMACOTHERAPY. Bd. 131. 2020
Huang, Kui; Madison, Terri; Wehler, Beatrice et al.
Effect of the patient information brochure in communicating the risks associated with crizotinib treatment to patients with non-small cell lung cancer (NSCLC) in EuropePHARMACOLOGY RESEARCH & PERSPECTIVES. Bd. 8. H. 2. 2020
Gkika, Eleni; Lenz, Stefan; Schimek-Jasch, Tanja et al.
Efficacy and Toxicity of Different Chemotherapy Protocols for Concurrent Chemoradiation in Non-Small Cell Lung Cancer-A Secondary Analysis of the PET Plan TrialCANCERS. Bd. 12. H. 11. 2020